Correction of Glycogen Storage Disease Type II by Enzyme Replacement with a Recombinant Human Acid Maltase Produced by Over-Expression in a CHO-DHFRneg Cell Line
Frank Martiniuk(Psychogenics (United States)), William N. Rom(New York University), Eleni Arvanitopoulos(Columbia University Irving Medical Center), Alfred E. Slonim(Nationwide Children's Hospital), Vincent Donnabella(Columbia University Irving Medical Center), Paul H. Plötz(National Institutes of Health), Nina Raben(APT Therapeutics (United States)), Agnes Chen(Columbia University Irving Medical Center)
Cited by 18
Related Papers
Therapy of Lupus Nephritis
|New England Journal of Medicine|1986|1.2k
A New Approach to the Classification of Idiopathic Inflammatory Myopathy
|Medicine|1991|974
A mechanism for the antiinflammatory effects of corticosteroids: the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1.
|Proceedings of the National Academy of Sciences|1992|730
Defective Reticuloendothelial System Fc-Receptor Function in Systemic Lupus Erythematosus
|New England Journal of Medicine|1979|531
Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy
|The Journal of Experimental Medicine|2005|395